DFO
ONC

Duquesne Family Office’s BeOne Medicines Ltd ONC Stock Holding History

Duquesne Family Office’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31,025
Closed -$8.89M – 81
2020
Q3 		$8.89M Buy
31,025
+4,845
+19% +$1.14M 0.26% 53
2020
Q2 		$4.93M Buy
+26,180
New +$4.26M 0.15% 61

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Duquesne Family Office's ONC Position: Q4 2020 in Review

Duquesne Family Office sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 31,025 shares — an estimated $8.89M sold.

Duquesne Family Office first reported a position in ONC in Q2 2020 and held it in 2 quarters. The position peaked at $8.89M in Q3 2020. 247 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Duquesne Family Office reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Duquesne Family Office sold 31,025 BeOne Medicines Ltd shares in Q4 2020, an estimated $8.89M.
  • Duquesne Family Office first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 2 quarters.
  • Duquesne Family Office's BeOne Medicines Ltd position peaked at $8.89M in Q3 2020.
  • 247 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Duquesne Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.